Preoperative Endoscopy and Its Impact on Perioperative Management in Bariatric Surgery by Wiltberger, Georg et al.
E-Mail karger@karger.com
 Original Paper 
 Dig Surg 2015;32:238–242 
 DOI: 10.1159/000381811 
 Preoperative Endoscopy and Its Impact 
on Perioperative Management in 
Bariatric Surgery 
 Georg Wiltberger  a    Julian Nikolaus Bucher  a, b    Moritz Schmelzle  a, c    
Albrecht Hoffmeister  d    Arne Dietrich  e   
 a   Department of Visceral-, Transplantation-, Thoracic- and Vascular Surgery, University Hospital Leipzig,  Leipzig , 
 b   Department of Surgery, Munich University Hospital at Großhadern (LMU),  Munich ,  c   Department of General-, 
Visceral- and Transplant Surgery, Berlin University Hospital,  Berlin ,  d   Department of Medicine, Dermatology and 
Neurology, Division of Gastroenterology and Rheumatology, and  e   Department for Bariatric Surgery, University 
Hospital Leipzig,  Leipzig , Germany 
(8%). The surgical approach was changed in 4 cases (3%). 
 Conclusion: Routinely performed preoperative endoscopy 
before bariatric surgery revealed a high prevalence of gas-
trointestinal diseases with a significant impact on periop-
erative management in two thirds of the cases. Therefore, 
we recommend routine gastroscopy about 2–4 weeks prior 
to surgery.  © 2015 S. Karger AG, Basel 
 Introduction 
 Obesity is a worldwide epidemic disease with a preva-
lence of more than 20%. Germany has the highest preva-
lence of obesity in Europe  [1, 2] . It is associated with an 
increased risk of comorbidities such as type 2 diabetes, 
cardiovascular disease, gastroesophageal reflux disease 
(GERD) and several types of cancer  [3, 4] .
 Bariatric surgery remains the most effective treatment 
for morbid obesity when conservative therapy is insuffi-
cient and therefore is becoming more and more accepted. 
Consequently, in Germany the number of primary pro-
cedures for obesity has increased rapidly from 596 in 2005 
to 6,195 in 2011  [5] .
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 Abstract 
 Background: The role of preoperative upper-gastrointesti-
nal endoscopy for bariatric surgery is still understood only 
with controversy. The aim of this study was to evaluate the 
prevalence of endoscopic findings and its impact on periop-
erative management.  Methods: Patients who underwent 
bariatric surgery at our center between 2010 and 2013 were 
systematically analyzed from a prospective database.  Re-
sults: Two hundred and twelve patients with a median body 
mass index of 50 kg/m 2 (range 29–87) underwent 216 bar-
iatric procedures at our center between 2010 and 2013. All 
patients received preoperative upper endoscopy. In 159 
cases (75%), the endoscopy was performed at our center. 
These cases were included in this study. In 37 cases (23%), 
no abnormal findings were detected. In 122 cases (76%), 
 upper endoscopy revealed pathologies. No further treat-
ment was necessary in 24 cases (15%). Medical treatment 
was changed in 81 cases (51%). The operation was delayed 
due to medical treatment and re-endoscopy in 13 cases 
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 Because of morbid obesity and its frequent comorbid-
ities, an accurate preoperative evaluation for risk reduc-
tion of this highly elective surgical therapy is mandatory. 
However, the value of preoperative upper gastrointestinal 
endoscopy is still uncertain and yet not generally recom-
mended  [6] .
 Several studies showed only low prevalence of abnor-
mal findings (10–34%), whereas other studies reported an 
increased prevalence of gastrointestinal diseases in mor-
bidly obese patients, which may have an impact on the 
perioperative therapy or even on the surgical procedure 
 [7–11] .
 The aim of this study was to evaluate the prevalence of 
abnormal findings in preoperative endoscopy and its po-
tential impact on perioperative management.
 Material and Methods 
 Information on patients who were scheduled for bariatric sur-
gery between October 2010 and April 2013 was analyzed retro-
spectively from our prospective database (n = 212). All patients 
receiving the upper endoscopy at our interdisciplinary endoscopy 
unit were included into the study (n = 159). Fifty-three patients 
were excluded from the study since they underwent endoscopy 
elsewhere (preferably locally when living outside the city) and 
hence the results were not documented.
 Prior to surgery, all patients attended an interdisciplinary 
weight loss program for more than 6 months, including frequent 
physical exercise, behavioral education and diet counseling; 
however, this did not lead to a significant weight loss. In all pa-
tients, preoperative upper endoscopy was performed by highly 
experienced physicians. Biopsies were taken routinely and ad-
ditionally if indicated by macroscopic pathologies. The endo-
scopic and histological findings were prospectively recorded in 
the study database. All patients who underwent preoperative up-
per endoscopy in an external hospital were excluded from this 
study.
 The updated Sydney System was used to classify the grade of 
gastritis  [12] . Esophagitis was classified according to Savary and 
Miller  [13] . Helicobacter pylori ( H. pylori ) colonization was tested 
using the rapid urease test and histological staining (silver stain-
ing). In case of a positive  H. pylori staining with no ulcer, postop-
erative eradication was recommended but did not cause a shift in 
the operation. In case of positive  H. pylori staining with ulceration, 
eradication and re-endoscopy was performed.
 Retrospectively we stratified the cases in five groups, according 
to the endoscopic findings and their impact on perioperative man-
agement:
 Group 1: no pathological findings in upper endoscopy; Group 
2: pathological findings which had no influence on the periop-
erative management; Group 3: pathological findings that altered 
the perioperative management but did not shift the operation; 
Group 4: pathological findings leading to delayed surgery; Group 
5: the surgical approach was changed because of endoscopic find-
ings.
 Results 
 Between October 2010 and April 2013, 212 patients 
(female n = 142) with a median age of 47 (range 19–71) 
and a median body mass index (BMI) of 50 kg/m 2 (range 
29–87) underwent either laparoscopic Sleeve Gastrecto-
my (n = 56), laparoscopic Roux-en-Y Gastric Bypass 
(LRYGB) (n = 150), laparoscopic Redo Procedure (Sleeve 
to bypass n = 8) or laparoscopic Duodenal-switch with 
Biliopancreatic Diversion (n = 2).
 In 37 cases (23%), no abnormal findings and in 122 
cases (76%) abnormal findings were detected as shown in 
 table 1 . In the latter group, 24 cases (15%) were not treat-
ed, the perioperative medical treatment was changed in 81 
cases, the operation was delayed due to medical treatment 
and mandantory re-endosocpy in 18 cases and abnormal 
findings changed the surgical approach in 4 patients. 
 Reflux esophagitis was found in 36 cases (23%) of 
which 28 cases (18%) were classified as reflux esophagitis 
Grade I and 8 (5%) as reflux esophagitis Grade II. No re-
flux esophagitis Grade III was found in any patient. Bar-
rett’s esophagus was found in 14 cases (9%) and this was 
confirmed by histology. Of these, one case was high-grade 
intraepithelial dysplasia with areas that were identified as 
a well-differentiated adenocarcinoma. It was staged as 
T1a N0 (according to UICC) by endoscopic ultrasonog-
raphy and treated initially by endoscopic mucosectomy. 
However, a complete resection was not achieved. There-
fore, the patient was scheduled for a modified laparoscop-
ic, transhiatal extended cardia-resection with reconstruc-
tion as LRYGB.
 Hiatal hernias were found in 34 cases (21%) of which 
most cases (n = 31; 19%) were small and needed no fur-
ther treatment. In 3 cases (2%) of larger hiatal hernias, an 
additional hiatus repair was performed.
 Gastric or duodenal ulcers were found in 83 cases (53%) 
of which 71 (45%) were superficial ulcers. In this case, a 
high dose of proton pump inhibitors (PPI) were given but 
no shift of the operation was necessary. In 12 cases (8%), 
deep ulcers where detected and this finding led to a shift of 
the operation.  H. pylori colonization was detected in 35 
cases (22%) and pre- or postoperative eradication was in-
dicated, without a shift of the operation if no deep ulcer-
ation was present. All 12 patients with deep ulcers had pos-
itive  H. pylori colonization and received preoperative erad-
ication therapy and re-endoscopy before surgery.
 No esophageal or gastric varices were detected in any 
patient, whereas in 8 cases (5%), gastric polyps were de-





















   
   
   
   
   
   
   
   
   
   
   


























 In one patient, a gastric adenocarcinoma was not de-
tected by preoperative endoscopy. However, intraopera-
tively, a tumor mass was seen and gastric carcinoma was 
confirmed by intraoperative frozen section. The surgical 
approach was adapted intraoperatively and the patient re-
ceived a subtotal gastrectomy with Roux-en-Y recon-
struction.
 Discussion 
 An accurate preoperative evaluation may be useful in 
order to reduce perioperative complications in obese pa-
tients. However, the role of preoperative endoscopy is still 
discussed controversially. The central aim of this study 
was to evaluate the prevalence of preoperative endoscop-
ic findings in patients scheduled for bariatric surgery and 
its potential impact on perioperative management. Our 
results showed that gastrointestinal disorders in obese 
 patients are frequent and had an influence on the periop-
erative course in 62% of the cases.
 Although no official guideline recommendations ex-
ist, we consider preoperative upper endoscopy essential 
for the detection of gastrointestinal diseases before bar-
iatric surgery. This approach is supported by other stud-
ies that found abnormalities in preoperatively performed 
endoscopy in 77–91% of the patients  [7, 14, 15] . Major 
findings in these studies were distal esophagitis in 38.9 
Table 1. Results of upper GI endoscopy prior to planned bariatric surgery
Total  Pathological findings and consequences for planned surgery





















n 159 (100) 37 (23) 24 (15) 81 (51) 13 (8) 4 (3)
Female 104 (65) 25 (68) 13 (54) 58 (72) 6 (46) 2 (50)
Age, median (mean) 48 (46) 48 (44) 46 (44) 48 (47) 51 (51) 54 (53)
BMI, median (mean) 50 (52) 50 (55) 50 (53) 48 (51) 54 (54) 48 (49)
Reflux esophagitis
Grade I 28 (18) 0 11 (46) 14 (17) 2 (15) 1 (25)
Grade II 8 (5) 0 2 (8) 3 (4) 1 (8) 2 (50)
Grade III 0 0 0 0 0 0
Barrett’s esophagus
No dysplasia 13 (8) 0 0 10 (12) 1 (8) 2 (50)
High grade dysplasia 1 (0.6) 0 0 0 0 1AC (25)
Hiatal hernia
Small 31 (19) 0 16 (67) 11 (14) 3 (23) 1 (25)
Large 3 (2) 0 0 0 0 3 (75)
Gastritis
Superficial erosions 71 (45) 0 0 62 (77) 6 (46) 3 (75)
Ulcers 12 (8) 0 0 0 12 (92) 0
Hp 35 (22) 0 0 27 (33) 8 (61) 0
Gastric polyps 8 (5) 0 2 (8) 6 (7) 0 0
Perioperative management
High dose PPI 98 (62) 0 0 81 (100) 13 (100) 4 (100)
Hp-eradication 35 (22) 0 0 27 (33) 8 (61) 0
Delay of surgery 14 (9) 0 0 0 13 (100) 1 (25)
Change of planned procedure 4 (3) 0 0 0 (1)a 0 4 (100)
 Results in total numbers or % of group/total. Hp = Helicobacter pylori infection; AC = invasive adenocarcinoma.
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and 24% of the cases. In our study, however, only 19% of 
the cases with pathological findings revealed distal esoph-
agitis, which could be explained by the frequent, self-de-
pendent use of PPIs in our cohort. Generally, in obese 
patients, the rate of esophagitis is higher than in the nor-
mal weight population  [15] .
 The rates of pathological findings that influenced 
the perioperative course (e.g. additional medical treat-
ment, postposition the date of the operation or change 
in the surgical approach) differs from 0.4 to 9% in the 
current literature. The study of de Moura Almeida et al. 
included 162 patients who underwent preoperative en-
doscopy before bariatric surgery and revealed that 
 gastric ulcers only led to a delayed operation in 1.9% of 
all patients  [7] . Furthermore, none of the 14 detected 
hiatal hernias (8.6%) led to a change in surgical ap-
proach.
 In the series of studies by Zeni et al.  [8], preoperative 
upper endoscopy revealed pathological findings, which 
delayed or altered the perioperative course before under-
going LRYGB in 15 patients (9%). Most findings were 
large and/or symptomatic hiatal hernias (5%), leading to 
simultaneous hernia repair. Furthermore, gastroduode-
nal ulcers led to delayed surgery and re-endoscopy to 
confirm the success of medical treatment in 4 patients 
(2%). In 2 patients (1%) pathological findings changed 
the surgical procedure and in one patient, a gastrointes-
tinal stromal tumor (GIST) was detected and subtotal 
gastrectomy had to be performed. In another patient, a 
gastric polyp was treated with a partial gastrectomy  [8] . 
In contrast to these studies, our results showed a higher 
rate of pathological results having an influence on peri-
operative management. In 12 cases (8%), severe ulcer-
ations with positive  H. pylori colonization were detected 
and the operation had to be shifted for eradication thera-
py and re-endoscopy.
 According to the pathological findings that changed 
the surgical approach, our results showed similar rates as 
reported by Zeni et al.  [8] . In 3 patients (2%), the surgical 
approach had to be adapted due to major hiatal hernias 
(simultaneous hernia repair) and in one patient due to 
esophageal adenocarcinoma. The latter patient received a 
modified laparoscopic transhiatal extended resection of 
the cardia with a reconstruction as LRYGB after insuffi-
cient endoscopic mucosectomy.
 In a further study of Loewen et al., 447 consecutive pa-
tients underwent routine upper endoscopy before bariat-
ric surgery. Endoscopic findings were classified accord-
ing to the suggestion of Sharaf et al. in a modified manner 
into four groups: Group 0 without abnormal findings; 
Group 1 was divided into two subgroups, whereas Group 
1 had abnormal findings that did not change the preop-
erative course and Group 1a had abnormal findings that 
changed the medical management but did not change the 
surgical approach or shift the operation; Group 2 had 
 abnormal findings that changed the surgical approach or 
delayed surgery and Group 3 with absolute contraindica-
tions for surgery  [16] . In contrast to other studies, only 
30% of all evaluated patients had abnormal findings and 
2 patients (0.4%) had pathological results that postponed 
surgery  [17] .
 In summary, our study showed that routinely per-
formed preoperative upper endoscopy in patients sched-
uled for bariatric surgery revealed a high prevalence of 
gastrointestinal diseases. Furthermore, we could show 
that these pathological findings had a potential im-
pact on perioperative management in two thirds of all 
cases.
 For this reason, we recommend routine gastroscopy 
about 2–4 weeks prior to planed surgery. This may be 
even more important for centers doing mainly Sleeve-
Gastrectomy. Here, for patients with GERD, bypass sur-
gery should be considered an alternative.
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